NOVORAPID Side Effects

7014560-8 | Blood Lactic Acid Increased, Pain In Extremity
on Sep 14, 2010 Male patient from SWITZERLAND , 48 years of age, was diagnosed with type 1 diabetes mellitus, pain in extremity and was treated with Novorapid (View Usage). Patient experienced the following unwanted or unexpected effects: blood lactic acid increased, pain in extremity. Novorapid dosage: Unk. During the same period patient was treated with LANTUS (26 Iu, Qd) (View Lantus Review and Lantus Label ), LYRICA (View Lyrica Review and Lyrica Label ), ASPIRIN (100 Mg, Qd) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6976074-0 | Hypoglycaemia Neonatal, Premature Baby
Patient was taking Novorapid (View Usage). Patient had the following side effects: hypoglycaemia neonatal, premature baby on Aug 31, 2010 from AUSTRALIA Additional patient health information: Female patient , weighting 4.41 lb, was diagnosed with type 2 diabetes mellitus and. Novorapid dosage: . During the same period patient was treated with PROTAPHANE (Unk) (View Protaphane Review and Protaphane Label ), METFORMIN (View Metformin Review and Metformin Label ).

6969229-2 | Neonatal Respiratory Distress Syndrome
Adverse event was reported on Sep 02, 2010 by a Male patient taking Novorapid (View Usage) (Dosage: 28 Iu, Qd) was diagnosed with type 1 diabetes mellitus and. Location: GEORGIA , weighting 7.05 lb, After Novorapid was administered, patient had the following side effects: neonatal respiratory distress syndrome. During the same period patient was treated with INSULATARD (18 Iu, Qd) (View Insulatard Review and Insulatard Label ), MAGNE B6 /00869101/ (Unk) (View Magne B6 /00869101/ Review and Magne B6 /00869101/ Label ), FERRO FOLGAMMA (Unk) (View Ferro Folgamma Review and Ferro Folgamma Label ), POTASSIUM IODIDE (Unk) (View Potassium Iodide Review and Potassium Iodide Label ). Patient was hospitalized.

6944970-6 | Blood Glucose Increased, Laryngeal Dysplasia, Lower Respiratory Tract Infection, Lung Infection, Pseudomonas Infection
on Aug 20, 2010 Female patient from AUSTRALIA , weighting 140.0 lb, was diagnosed with insulin-requiring type 2 diabetes mellitus and was treated with Novorapid (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, laryngeal dysplasia, lower respiratory tract infection, lung infection, pseudomonas infection. Novorapid dosage: 6 U, Tid. During the same period patient was treated with ACTRAPID HM PENFILL (6+4+6 U, Qd) (View Actrapid Hm Penfill Review and Actrapid Hm Penfill Label ), PROTAPHANE PENFILL (4 U At Night, Qd For One Week.) (View Protaphane Penfill Review and Protaphane Penfill Label ), LANTUS (18 U, Qd At Night) (View Lantus Review and Lantus Label ). Patient was hospitalized.


6938284-8 | Hypoglycaemic Unconsciousness, Impaired Gastric Emptying
on Aug 13, 2010 Female patient from AUSTRALIA , 40 years of age, was diagnosed with type 1 diabetes mellitus and was treated with Novorapid (View Usage). Patient had the following side effects: hypoglycaemic unconsciousness, impaired gastric emptying. Novorapid dosage: . Patient was hospitalized.

6866457-1 | Blood Glucose Increased, Lower Respiratory Tract Infection, Lung Infection, Pseudomonas Infection, Throat Cancer
Patient was taking Novorapid (View Usage). After Novorapid was administered, patient had the following side effects: blood glucose increased, lower respiratory tract infection, lung infection, pseudomonas infection, throat cancer on Jul 12, 2010 from AUSTRALIA Additional patient health information: Female patient , weighting 140.0 lb, was diagnosed with insulin-requiring type 2 diabetes mellitus and. Novorapid dosage: 6 U, Tid. During the same period patient was treated with ACTRAPID HM PENFILL (6+4+6 U, Qd) (View Actrapid Hm Penfill Review and Actrapid Hm Penfill Label ), PROTAPHANE PENFILL (4 U At Night, Qd For One Week.) (View Protaphane Penfill Review and Protaphane Penfill Label ), LANTUS (18 U, Qd At Night) (View Lantus Review and Lantus Label ). Patient was hospitalized.

6866426-1 | Blood Glucose Increased, Diabetes Mellitus Inadequate Control, Encephalitis Viral, Hypoglycaemia, Lipohypertrophy, Loss Of Consciousness
Adverse event was reported on Jul 13, 2010 by a Female patient taking Novorapid (View Usage) (Dosage: 17 U, Qd) was diagnosed with type 2 diabetes mellitus and. Location: AUSTRALIA , 83 years of age, Patient experienced the following unwanted or unexpected effects: blood glucose increased, diabetes mellitus inadequate control, encephalitis viral, hypoglycaemia, lipohypertrophy, loss of consciousness. During the same period patient was treated with LANTUS (5 U, Qd) (View Lantus Review and Lantus Label ). Patient was hospitalized.

6862272-3 | Caesarean Section, Neonatal Respiratory Distress Syndrome
on Jul 10, 2010 Male patient from GEORGIA , weighting 7.05 lb, was diagnosed with type 1 diabetes mellitus and was treated with Novorapid (View Usage). Patient had the following side effects: caesarean section, neonatal respiratory distress syndrome. Novorapid dosage: 28 Iu, Qd. During the same period patient was treated with INSULATARD (18 Iu, Qd) (View Insulatard Review and Insulatard Label ), MAGNE B6 /00869101/ (Unk) (View Magne B6 /00869101/ Review and Magne B6 /00869101/ Label ), FERRO FOLGAMMA (Unk) (View Ferro Folgamma Review and Ferro Folgamma Label ), POTASSIUM IODIDE (Unk) (View Potassium Iodide Review and Potassium Iodide Label ). Patient was hospitalized.

6812181-0 | Blood Glucose Abnormal, Blood Glucose Increased, Diabetic Ketoacidosis, Hyperglycaemia
on May 10, 2010 Female patient from SWEDEN , 38 years of age, weighting 330.7 lb, was diagnosed with type 1 diabetes mellitus and was treated with Novorapid (View Usage). After Novorapid was administered, patient had the following side effects: blood glucose abnormal, blood glucose increased, diabetic ketoacidosis, hyperglycaemia. Novorapid dosage: Between 80-90 Iu Daily. During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

6812179-2 | Cerebral Venous Thrombosis
Patient was taking Novorapid (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral venous thrombosis on Jun 22, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 17 years of age, weighting 139.6 lb, was diagnosed with type 1 diabetes mellitus and. Novorapid dosage: 10-15 Iu, Tid. During the same period patient was treated with LANTUS (32 Iu, Qd) (View Lantus Review and Lantus Label ). Patient was hospitalized.

6803497-2 | Hypoglycaemic Coma, Hypothermia
Adverse event was reported on Jun 23, 2010 by a Female patient taking Novorapid (View Usage) (Dosage: 12 Iu, Qd) was diagnosed with type 1 diabetes mellitus, anaemia and. Location: FRANCE , 31 years of age, Patient had the following side effects: hypoglycaemic coma, hypothermia (What is hypothermia?). During the same period patient was treated with LANTUS (12 Iu, Qd) (View Lantus Review and Lantus Label ), NEORECORMON (View Neorecormon Review and Neorecormon Label ).

6790122-2 | Anti-insulin Antibody, Blood Glucose Fluctuation, Diabetes Mellitus Inadequate Control, Hyperglycaemia, Hypoglycaemia, Insulin Resistance Syndrome
on Jun 15, 2010 Male patient from FRANCE , 35 years of age, weighting 160.9 lb, was diagnosed with type 1 diabetes mellitus and was treated with Novorapid (View Usage). After Novorapid was administered, patient had the following side effects: anti-insulin antibody, blood glucose fluctuation, diabetes mellitus inadequate control, hyperglycaemia, hypoglycaemia, insulin resistance syndrome. Novorapid dosage: 300 To 400 U/ Day. During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ). Patient was hospitalized.

6781330-5 | Blood Glucose Increased, Diabetes Mellitus Inadequate Control, Hypoglycaemia, Lipohypertrophy, Loss Of Consciousness
on Jun 10, 2010 Female patient from AUSTRALIA , 83 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Novorapid (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, diabetes mellitus inadequate control, hypoglycaemia, lipohypertrophy, loss of consciousness. Novorapid dosage: 17 U, Qd. During the same period patient was treated with LANTUS (5 U, Qd) (View Lantus Review and Lantus Label ). Patient was hospitalized.

6775129-3 | Blood Glucose Abnormal, Blood Glucose Increased, Diabetic Ketoacidosis, Hyperglycaemia
Patient was taking Novorapid (View Usage). Patient had the following side effects: blood glucose abnormal, blood glucose increased, diabetic ketoacidosis, hyperglycaemia on Jun 07, 2010 from SWEDEN Additional patient health information: Female patient , 38 years of age, weighting 330.7 lb, was diagnosed with type 1 diabetes mellitus and. Novorapid dosage: Between 80-90 Iu Daily. During the same period patient was treated with METFORMIN (View Metformin Review and Metformin Label ). Patient was hospitalized.

6721411-5 | Caesarean Section, Pre-eclampsia, Pregnancy
Adverse event was reported on May 06, 2010 by a Female patient taking Novorapid (View Usage) (Dosage: 22 Iu, Qd) was diagnosed with type 1 diabetes mellitus and. Location: GEORGIA , 23 years of age, weighting 121.3 lb, After Novorapid was administered, patient had the following side effects: caesarean section, pre-eclampsia, pregnancy (What is pregnancy?). During the same period patient was treated with INSULATARD (42 Iu, Qd) (View Insulatard Review and Insulatard Label ), ACTRAPID (42 Iu, Qd) (View Actrapid Review and Actrapid Label ), MAGNE B6 /00869101/ (2x3 Tab, Qd) (View Magne B6 /00869101/ Review and Magne B6 /00869101/ Label ). Patient was hospitalized.

6676283-4 | Anti-insulin Antibody, Blood Glucose Fluctuation, Diabetes Mellitus Inadequate Control, Hyperglycaemia, Hypoglycaemia, Insulin Resistance Syndrome
on Apr 02, 2010 Male patient from FRANCE , 35 years of age, was diagnosed with type 1 diabetes mellitus and was treated with Novorapid (View Usage). Patient experienced the following unwanted or unexpected effects: anti-insulin antibody, blood glucose fluctuation, diabetes mellitus inadequate control, hyperglycaemia, hypoglycaemia, insulin resistance syndrome. Novorapid dosage: 300 To 400 U/ Day. During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ). Patient was hospitalized.

6660802-8 | Headache, Hypertension, Malaise, Palpitations, Pregnancy, Tachycardia
on Mar 24, 2010 Female patient from NEW ZEALAND , 36 years of age, was diagnosed with gestational diabetes and was treated with Novorapid (View Usage). Patient had the following side effects: headache (What is headache?), hypertension, malaise, palpitations, pregnancy (What is pregnancy?), tachycardia. Novorapid dosage: 12 U, Qd. During the same period patient was treated with PROTAPHANE (8 U, Qd) (View Protaphane Review and Protaphane Label ). Patient was hospitalized.

6660656-X | Cerebral Venous Thrombosis
Patient was taking Novorapid (View Usage). After Novorapid was administered, patient had the following side effects: cerebral venous thrombosis on Mar 22, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 17 years of age, was diagnosed with type 1 diabetes mellitus and. Novorapid dosage: Unk. During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ). Patient was hospitalized.

6607750-7 | Dyspnoea, Erythema, Face Oedema, Oedema Peripheral
Adverse event was reported on Feb 18, 2010 by a Female patient taking Novorapid (View Usage) (Dosage: ) . Location: BRAZIL , 63 years of age, weighting 123.5 lb, Patient experienced the following unwanted or unexpected effects: dyspnoea, erythema, face oedema, oedema peripheral. During the same period patient was treated with ENOXAPARIN SODIUM (40 Mg, Qd) (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), CLINDAMYCIN (1800 Mg, Qd) (View Clindamycin Review and Clindamycin Label ), CEFTRIAXONE (2000 Mg, Qd) (View Ceftriaxone Review and Ceftriaxone Label ). Patient was hospitalized.

6601427-X | Caesarean Section, Delayed Delivery, Pregnancy Induced Hypertension
on Feb 15, 2010 Female patient from DENMARK , 23 years of age, weighting 149.9 lb, was treated with Novorapid (View Usage). Patient had the following side effects: caesarean section, delayed delivery, pregnancy induced hypertension. Novorapid dosage: 43 Iu, Qd. During the same period patient was treated with LEVEMIR (30 Iu, Qd) (View Levemir Review and Levemir Label ). Patient was hospitalized.

6599252-1 | Amyloidosis
on Feb 15, 2010 Male patient from GERMANY , 33 years of age, was diagnosed with type 1 diabetes mellitus and was treated with Novorapid (View Usage). After Novorapid was administered, patient had the following side effects: amyloidosis. Novorapid dosage: Unk. During the same period patient was treated with LEVEMIR (Unk) (View Levemir Review and Levemir Label ), LANTUS (Unk) (View Lantus Review and Lantus Label ). Patient was hospitalized.

6579128-6 | Blood Glucose Fluctuation, Diabetes Mellitus Inadequate Control, Hyperglycaemia, Hypoglycaemia, Insulin Resistance Syndrome
Patient was taking Novorapid (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose fluctuation, diabetes mellitus inadequate control, hyperglycaemia, hypoglycaemia, insulin resistance syndrome on Feb 05, 2010 from FRANCE Additional patient health information: Male patient , 35 years of age, was diagnosed with type 1 diabetes mellitus and. Novorapid dosage: 300 To 400 U/ Day. During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ). Patient was hospitalized.

6574420-3 | Pre-eclampsia, Pregnancy
Adverse event was reported on Jan 26, 2010 by a Female patient taking Novorapid (View Usage) (Dosage: 22 Iu, Qd) was diagnosed with type 1 diabetes mellitus and. Location: GEORGIA , 23 years of age, weighting 121.3 lb, Patient had the following side effects: pre-eclampsia, pregnancy (What is pregnancy?). During the same period patient was treated with INSULATARD (15 Iu, Qd) (View Insulatard Review and Insulatard Label ), ACTRAPID (42 Iu, Qd) (View Actrapid Review and Actrapid Label ), MAGNE B6 /00869101/ (2x3 Tab, Qd) (View Magne B6 /00869101/ Review and Magne B6 /00869101/ Label ), FERRO FOLGAMMA /01256801/ (1x3 Tab, Qd) (View Ferro-folgamma /01256801/ Review and Ferro-folgamma /01256801/ Label ). Patient was hospitalized.

6546464-9 | Cerebral Haemorrhage Neonatal, Paresis
on Jan 13, 2010 Female patient from SERBIA , weighting 10.47 lb, was diagnosed with type 1 diabetes mellitus and was treated with Novorapid (View Usage). After Novorapid was administered, patient had the following side effects: cerebral haemorrhage neonatal, paresis. Novorapid dosage: 12 Iu, Unk. During the same period patient was treated with LEVEMIR (Unk) (View Levemir Review and Levemir Label ).

6543890-9 | Blood Glucose Fluctuation, Diabetes Mellitus Inadequate Control, Hyperglycaemia, Hypoglycaemia, Insulin Resistance Syndrome
on Jan 12, 2010 Male patient from FRANCE , 35 years of age, was diagnosed with type 1 diabetes mellitus and was treated with Novorapid (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose fluctuation, diabetes mellitus inadequate control, hyperglycaemia, hypoglycaemia, insulin resistance syndrome. Novorapid dosage: 300 To 400 U/ Day. During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ). Patient was hospitalized.

6523683-9 | Cerebral Haemorrhage Neonatal, Paresis
Patient was taking Novorapid (View Usage). Patient had the following side effects: cerebral haemorrhage neonatal, paresis on Dec 22, 2009 from SERBIA Additional patient health information: Female patient , weighting 10.47 lb, was diagnosed with type 1 diabetes mellitus and. Novorapid dosage: 12 Iu, Unk. During the same period patient was treated with LEVEMIR (Unk) (View Levemir Review and Levemir Label ).

6520282-X | Insulin Resistance
Adverse event was reported on Dec 22, 2009 by a Female patient taking Novorapid (View Usage) (Dosage: 60 Iu, Qd) was diagnosed with type 1 diabetes mellitus and. Location: UNITED KINGDOM , 15 years of age, weighting 141.1 lb, After Novorapid was administered, patient had the following side effects: insulin resistance. Patient was hospitalized and became disabled.

6517755-2 | Abortion Spontaneous
on Dec 08, 2009 Female patient from CANADA , weighting 249.1 lb, was diagnosed with gestational diabetes, hypertension and was treated with Novorapid (View Usage). Patient experienced the following unwanted or unexpected effects: abortion spontaneous. Novorapid dosage: . During the same period patient was treated with PERINDOPRIL ERBUMINE 4MG F51 TABLET (Daily Dose: 4 Milligram(s)) (View Perindopril Erbumine 4mg-f51 Tablet Review and Perindopril Erbumine 4mg-f51 Tablet Label ), NPH INSULIN (View Nph Insulin Review and Nph Insulin Label ).

6507081-X | Altered State Of Consciousness, Fall, Hypoglycaemia, Microcytic Anaemia, Treatment Noncompliance, Weight Decreased
on Dec 08, 2009 Male patient from FRANCE , 83 years of age, was diagnosed with type 1 diabetes mellitus, hypothyroidism and was treated with Novorapid (View Usage). Patient had the following side effects: altered state of consciousness, fall (What is fall?), hypoglycaemia, microcytic anaemia, treatment noncompliance, weight decreased. Novorapid dosage: 74 Iu, Qd. During the same period patient was treated with LANTUS (44 Iu, Qd) (View Lantus Review and Lantus Label ), PREVISCAN /00789001/ (10 Mg, Qd) (View Previscan /00789001/ Review and Previscan /00789001/ Label ), AMLOR (10 Mg, Qd) (View Amlor Review and Amlor Label ), ELISOR (40 Mg, Qd) (View Elisor Review and Elisor Label ), LEVOTHYROXINE SODIUM (75 Ug, Qd) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), RENITEC /00574901/ (20 Mg, Qd) (View Renitec /00574901/ Review and Renitec /00574901/ Label ), TEMERIT /01339101/ (5 Mg, Qd) (View Temerit /01339101/ Review and Temerit /01339101/ Label ), ZYLORIC /00003301/ (200 Mg, Qd) (View Zyloric /00003301/ Review and Zyloric /00003301/ Label ). Patient was hospitalized.

6502859-0 | Abortion Spontaneous, Pregnancy
Patient was taking Novorapid (View Usage). After Novorapid was administered, patient had the following side effects: abortion spontaneous, pregnancy (What is pregnancy?) on Dec 08, 2009 from CANADA Additional patient health information: Female patient , weighting 249.1 lb, was diagnosed with gestational diabetes, hypertension and. Novorapid dosage: . During the same period patient was treated with PERINDOPRIL ERBUMINE 4MG F51 TABLET (Daily Dose: 4 Milligram(s)) (View Perindopril Erbumine 4mg-f51 Tablet Review and Perindopril Erbumine 4mg-f51 Tablet Label ), NPH INSULIN (View Nph Insulin Review and Nph Insulin Label ).

6456586-9 | Altered State Of Consciousness, Fall, Hypoglycaemia, Microcytic Anaemia, Treatment Noncompliance, Weight Decreased
Adverse event was reported on Nov 16, 2009 by a Male patient taking Novorapid (View Usage) (Dosage: 74 Iu, Qd) was diagnosed with type 1 diabetes mellitus, hypothyroidism and. Location: FRANCE , 83 years of age, Patient experienced the following unwanted or unexpected effects: altered state of consciousness, fall (What is fall?), hypoglycaemia, microcytic anaemia, treatment noncompliance, weight decreased. During the same period patient was treated with LANTUS (44 Iu, Qd) (View Lantus Review and Lantus Label ), PREVISCAN /00261401/ (10 Mg, Qd) (View Previscan /00261401/ Review and Previscan /00261401/ Label ), AMLOR (10 Mg, Qd) (View Amlor Review and Amlor Label ), PRAVASTATIN (40 Mg, Qd) (View Pravastatin Review and Pravastatin Label ), LEVOTHYROXINE SODIUM (75 Ug, Qd) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), RENITEC /00574901/ (20 Mg, Qd) (View Renitec /00574901/ Review and Renitec /00574901/ Label ), TEMERIT /01339101/ (5 Mg, Qd) (View Temerit /01339101/ Review and Temerit /01339101/ Label ), ZYLORIC /00003301/ (200 Mg, Qd) (View Zyloric /00003301/ Review and Zyloric /00003301/ Label ). Patient was hospitalized.

6446563-6 | Viral Infection
on Nov 12, 2009 Female patient from UNITED KINGDOM , weighting 170.6 lb, was diagnosed with type 1 diabetes mellitus and was treated with Novorapid (View Usage). Patient had the following side effects: viral infection (What is viral infection?). Novorapid dosage: 20 Iu, Qd (15+5). Patient was hospitalized.

6443454-1 | Caesarean Section, Delayed Delivery, Hypertension
on Nov 06, 2009 Female patient from DENMARK , 23 years of age, weighting 149.9 lb, was treated with Novorapid (View Usage). After Novorapid was administered, patient had the following side effects: caesarean section, delayed delivery, hypertension. Novorapid dosage: . During the same period patient was treated with LEVEMIR (View Levemir Review and Levemir Label ). Patient was hospitalized.

6439245-8 | Injection Site Abscess, Pyrexia
Patient was taking Novorapid (View Usage). Patient experienced the following unwanted or unexpected effects: injection site abscess, pyrexia on Nov 03, 2009 from NETHERLANDS Additional patient health information: Female patient , 52 years of age, weighting 205.0 lb, was diagnosed with type 1 diabetes mellitus and. Novorapid dosage: Unk.

6437699-4 | Blood Glucose Increased, Lower Respiratory Tract Infection, Lung Infection, Pseudomonas Infection, Throat Cancer
Adverse event was reported on Nov 02, 2009 by a Female patient taking Novorapid (View Usage) (Dosage: 6 U, Tid) was diagnosed with insulin-requiring type 2 diabetes mellitus and. Location: AUSTRALIA , weighting 140.0 lb, Patient had the following side effects: blood glucose increased, lower respiratory tract infection, lung infection, pseudomonas infection, throat cancer. During the same period patient was treated with ACTRAPID HM PENFILL (6+4+6 U, Qd) (View Actrapid Hm Penfill Review and Actrapid Hm Penfill Label ), PROTAPHANE PENFILL (4 U At Night, Qd For One Week.) (View Protaphane Penfill Review and Protaphane Penfill Label ), LANTUS (18 U, Qd At Night) (View Lantus Review and Lantus Label ). Patient was hospitalized.

6419214-4 | Ketosis
on Oct 19, 2009 Female patient from UNITED KINGDOM , weighting 170.6 lb, was diagnosed with type 1 diabetes mellitus and was treated with Novorapid (View Usage). After Novorapid was administered, patient had the following side effects: ketosis. Novorapid dosage: 20 Iu, Qd (15+5). Patient was hospitalized.

6412135-2 | Injection Site Abscess
on Oct 13, 2009 Female patient from NETHERLANDS , 52 years of age, was diagnosed with type 1 diabetes mellitus and was treated with Novorapid (View Usage). Patient experienced the following unwanted or unexpected effects: injection site abscess. Novorapid dosage: . During the same period patient was treated with FLUCLOXACILLINE /00239101/ (500mg, Tid) (View Flucloxacilline /00239101/ Review and Flucloxacilline /00239101/ Label ).

6399940-6 | Umbilical Cord Vascular Disorder
Patient was taking Novorapid (View Usage). Patient had the following side effects: umbilical cord vascular disorder on Oct 07, 2009 from DENMARK Additional patient health information: Female patient , weighting 4.91 lb, was diagnosed with type 1 diabetes mellitus and. Novorapid dosage: . During the same period patient was treated with INSULATARD FLEXPEN (View Insulatard Flexpen Review and Insulatard Flexpen Label ).

6394709-0 | Oedema
Adverse event was reported on Sep 30, 2009 by a Female patient taking Novorapid (View Usage) (Dosage: 4+2 Iu) was diagnosed with type 1 diabetes mellitus and. Location: RUSSIAN FEDERATION , 35 years of age, weighting 110.2 lb, After Novorapid was administered, patient had the following side effects: oedema. During the same period patient was treated with CAVINTON (View Cavinton Review and Cavinton Label ), STUGERON (View Stugeron Review and Stugeron Label ), L THYROXINE /00068001/ (View L-thyroxine /00068001/ Review and L-thyroxine /00068001/ Label ). Patient was hospitalized.

6387929-2 | Injection Site Abscess
on Sep 25, 2009 Female patient from NETHERLANDS , 52 years of age, was diagnosed with type 1 diabetes mellitus and was treated with Novorapid (View Usage). Patient experienced the following unwanted or unexpected effects: injection site abscess. Novorapid dosage: . During the same period patient was treated with FLUCLOXACILLINE /00239101/ (500mg, Tid) (View Flucloxacilline /00239101/ Review and Flucloxacilline /00239101/ Label ).

6384476-9 | Diabetic Foetopathy
on Sep 23, 2009 Male patient from CZECH REPUBLIC , weighting 5.73 lb, was diagnosed with type 1 diabetes mellitus and was treated with Novorapid (View Usage). Patient had the following side effects: diabetic foetopathy. Novorapid dosage: 49 Iu, Qd. During the same period patient was treated with LIZINOPRILS (View Lizinoprils Review and Lizinoprils Label ). Patient was hospitalized.

6382788-6 | Ketosis
Patient was taking Novorapid (View Usage). After Novorapid was administered, patient had the following side effects: ketosis on Sep 21, 2009 from UNITED KINGDOM Additional patient health information: Female patient , weighting 170.6 lb, was diagnosed with type 1 diabetes mellitus and. Novorapid dosage: . Patient was hospitalized.

6379227-8 | Injection Site Erythema, Injection Site Pustule, Injection Site Swelling, Injection Site Warmth
Adverse event was reported on Sep 18, 2009 by a Female patient taking Novorapid (View Usage) (Dosage: ) was diagnosed with type 1 diabetes mellitus and. Location: NETHERLANDS , 52 years of age, Patient experienced the following unwanted or unexpected effects: injection site erythema, injection site pustule, injection site swelling, injection site warmth. During the same period patient was treated with FLUCLOXACILLINE /00239101/ (500mg, Tid) (View Flucloxacilline /00239101/ Review and Flucloxacilline /00239101/ Label ).

6354480-5 | Diabetic Foetopathy
on Sep 03, 2009 Male patient from CZECH REPUBLIC , weighting 5.73 lb, was diagnosed with type 1 diabetes mellitus and was treated with Novorapid (View Usage). Patient had the following side effects: diabetic foetopathy. Novorapid dosage: 49 Iu, Qd. During the same period patient was treated with LIZINOPRILS (View Lizinoprils Review and Lizinoprils Label ). Patient was hospitalized.

6348965-5 | Anaphylactic Reaction, Blood Glucose Increased, Diabetic Ketoacidosis, Hypoglycaemia, Injection Site Nodule, Serum Sickness-like Reaction
on Jul 06, 2009 Female patient from TURKEY , 26 years of age, was diagnosed with type 1 diabetes mellitus and was treated with Novorapid (View Usage). After Novorapid was administered, patient had the following side effects: anaphylactic reaction, blood glucose increased, diabetic ketoacidosis, hypoglycaemia, injection site nodule, serum sickness-like reaction. Novorapid dosage: . During the same period patient was treated with INSULIN LISPRO (View Insulin Lispro Review and Insulin Lispro Label ), NPH INSULIN (View Nph Insulin Review and Nph Insulin Label ), INSULIN HUMAN (View Insulin Human Review and Insulin Human Label ).

6316267-9 | Abscess
Patient was taking Novorapid (View Usage). Patient experienced the following unwanted or unexpected effects: abscess (What is abscess?) on Aug 10, 2009 from GERMANY Additional patient health information: Female patient , weighting 315.3 lb, was diagnosed with type 2 diabetes mellitus, tachycardia and. Novorapid dosage: 100 Ie, Qd. During the same period patient was treated with LEVEMIR (40 Ie, Qd) (View Levemir Review and Levemir Label ), ACTRAPID (View Actrapid Review and Actrapid Label ), BISOPROLOL (5 Mg, Qd) (View Bisoprolol Review and Bisoprolol Label ), LEVOCETIRIZINE DIHYDROCHLORIDE (10 Mg, Qd) (View Levocetirizine Dihydrochloride Review and Levocetirizine Dihydrochloride Label ), GABAPENTIN (600 Mg, Qd) (View Gabapentin Review and Gabapentin Label ). Patient was hospitalized.

6309632-7 | Blood Glucose Abnormal, Blood Ketone Body
Adverse event was reported on Aug 03, 2009 by a Male patient taking Novorapid (View Usage) (Dosage: 25+ Iu, Unk) was diagnosed with type 1 diabetes mellitus and. Location: UNITED KINGDOM , child 9 years of age, weighting 52.69 lb, Patient had the following side effects: blood glucose abnormal, blood ketone body. During the same period patient was treated with NOVOMIX 30 (View Novomix 30 Review and Novomix 30 Label ), INSULATARD (View Insulatard Review and Insulatard Label ), LANTUS (View Lantus Review and Lantus Label ). Patient was hospitalized.

6290805-7 | Foetal Distress Syndrome, Hip Dysplasia, Hypocalcaemia, Hypoglycaemia, Inguinal Hernia, Jaundice Neonatal, Neonatal Respiratory Distress Syndrome, Premature Baby
on Jun 05, 2009 Female patient from UNITED KINGDOM , weighting 3.53 lb, was diagnosed with type 1 diabetes mellitus and was treated with Novorapid (View Usage). After Novorapid was administered, patient had the following side effects: foetal distress syndrome, hip dysplasia, hypocalcaemia, hypoglycaemia, inguinal hernia, jaundice neonatal, neonatal respiratory distress syndrome, premature baby. Novorapid dosage: 24 Iu, Qd. During the same period patient was treated with LEVEMIR (26 Iu, Qd) (View Levemir Review and Levemir Label ), NOVOMIX 30 FLEXPEN (View Novomix 30 Flexpen Review and Novomix 30 Flexpen Label ), VENTOLIN (View Ventolin Review and Ventolin Label ), PHOLCODINE LINCTUS (View Pholcodine Linctus Review and Pholcodine Linctus Label ), METOCLOPRAMIDE (10 G, Qd) (View Metoclopramide Review and Metoclopramide Label ), LACTULOSE (500 Ml, Qd) (View Lactulose Review and Lactulose Label ). Patient was hospitalized.

6270644-3 | Anaphylactic Reaction, Blood Glucose Increased, Diabetic Ketoacidosis, Hypoglycaemia, Injection Site Nodule, Oedema Peripheral, Serum Sickness-like Reaction
on Jul 06, 2009 Female patient from TURKEY , 26 years of age, was diagnosed with type 1 diabetes mellitus and was treated with Novorapid (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic reaction, blood glucose increased, diabetic ketoacidosis, hypoglycaemia, injection site nodule, oedema peripheral, serum sickness-like reaction. Novorapid dosage: . During the same period patient was treated with INSULIN LISPRO (View Insulin Lispro Review and Insulin Lispro Label ), NPH INSULIN (View Nph Insulin Review and Nph Insulin Label ), INSULIN HUMAN (View Insulin Human Review and Insulin Human Label ).

6259884-7 | Bacterial Infection, Diabetic Foot, Toe Amputation
Patient was taking Novorapid (View Usage). Patient had the following side effects: bacterial infection (What is bacterial infection?), diabetic foot, toe amputation on Jun 25, 2009 from POLAND Additional patient health information: Male patient , 53 years of age, weighting 198.4 lb, was diagnosed with insulin-requiring type 2 diabetes mellitus and. Novorapid dosage: 56 Iu, Qd. During the same period patient was treated with INSULATARD HM (28 Iu, Qd) (View Insulatard Hm Review and Insulatard Hm Label ), SIMVASTEROL (20 Mg, Qd) (View Simvasterol Review and Simvasterol Label ), HYGROTON (50 Mg, Qd) (View Hygroton Review and Hygroton Label ), ASPIRIN (75 Mg, Qd) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.